Achilles Therapeutics (ACHL) News Today $1.48 0.00 (0.00%) As of 03/26/2025 Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACHL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Achilles Therapeutics (ACHL) Projected to Post Quarterly Earnings on ThursdayMarch 27, 2025 | marketbeat.comAchilles Therapeutics plc (NASDAQ:ACHL) Short Interest UpdateMarch 15, 2025 | marketbeat.comAchilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC DeregistrationFebruary 28, 2025 | markets.businessinsider.comAchilles Therapeutics announces voluntary Nasdaq delisting, SEC deregistrationFebruary 28, 2025 | markets.businessinsider.comAchilles Therapeutics plc (NASDAQ:ACHL) Short Interest Up 1,280.4% in FebruaryFebruary 28, 2025 | marketbeat.comShort Interest in Achilles Therapeutics plc (NASDAQ:ACHL) Drops By 52.8%February 13, 2025 | marketbeat.comAchilles Transfers Technology Assets From TRACERx NSCLC Study To AstraZeneca For $12 Mln, Stock UpDecember 24, 2024 | markets.businessinsider.comAchilles Therapeutics Announces Sale of Technology Assets to AstraZenecaDecember 24, 2024 | globenewswire.comAchilles Therapeutics PLC: Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital MarketNovember 19, 2024 | finanznachrichten.deAchilles Therapeutics Receives Approval to Transfer to Nasdaq Capital MarketNovember 19, 2024 | globenewswire.comAchilles Therapeutics PLC: Achilles Therapeutics Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | finanznachrichten.deAchilles Therapeutics reports Q3 EPS (48c) vs. (42c) last yearNovember 14, 2024 | markets.businessinsider.comAchilles Therapeutics Explores Strategic Options Amid Financial UpdateNovember 14, 2024 | markets.businessinsider.comAchilles Therapeutics Reports Third Quarter 2024 Financial ResultsNovember 14, 2024 | globenewswire.comEuropean Equities Traded in the US as American Depositary Receipts Edge Higher in Monday TradingSeptember 24, 2024 | msn.comAchilles Therapeutics PLC: Achilles Therapeutics Announces Strategic UpdateSeptember 19, 2024 | finanznachrichten.deAchilles Therapeutics to Lay Off Staff as Part of Review, Discontinues Drug TrialsSeptember 19, 2024 | marketwatch.comAchilles Therapeutics ADRs Rise 32% on Cost-Cutting MeasuresSeptember 19, 2024 | marketwatch.comAchilles Therapeutics Discontinues TIL-based CNeT ProgramSeptember 19, 2024 | markets.businessinsider.comAchilles climbs after decision to find strategic alternativesSeptember 19, 2024 | msn.comAchilles Therapeutics Shares Are Trading Higher: What You Need To KnowSeptember 19, 2024 | msn.comAchilles Therapeutics Announces Strategic UpdateSeptember 19, 2024 | globenewswire.comAchilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business UpdatesAugust 14, 2024 | globenewswire.comAchilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation Personalized mRNA Cancer VaccinesMay 22, 2024 | globenewswire.comAchilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementMay 17, 2024 | globenewswire.comACHL Stock Earnings: Achilles Therapeutics Beats EPS for Q1 2024May 8, 2024 | investorplace.comAchilles Therapeutics PLC: Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | finanznachrichten.deAchilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsMay 8, 2024 | globenewswire.comAchilles Therapeutics plc - Depositary Receipt () (ACHL) Price Target Decreased by 56.41% to 2.89April 17, 2024 | msn.comPiper downgrades Achilles to neutral, cites latest dataApril 5, 2024 | msn.comACHL Stock Earnings: Achilles Therapeutics Misses EPS for Q4 2023April 4, 2024 | markets.businessinsider.comAchilles Therapeutics PLC: Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | finanznachrichten.deAchilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | globenewswire.comAchilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host ConditioningApril 4, 2024 | globenewswire.comAchilles Therapeutics (ACHL) to Release Earnings on TuesdayApril 1, 2024 | marketbeat.comWill Achilles Therapeutics (NASDAQ:ACHL) Spend Its Cash Wisely?March 7, 2024 | finance.yahoo.comAchilles Therapeutics (ACHL) Set to Announce Quarterly Earnings on TuesdayMarch 4, 2024 | marketbeat.comAchilles Therapeutics PLC ADRFebruary 22, 2024 | wsj.comAchilles Therapeutics Stock (NASDAQ:ACHL), Short Interest ReportFebruary 22, 2024 | benzinga.comAchilles Therapeutics PLC ADR (ACHL)February 9, 2024 | investing.comAchilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 ConferenceFebruary 5, 2024 | finance.yahoo.comAchilles Therapeutics Stock (NASDAQ:ACHL) Dividends: History, Yield and DatesDecember 21, 2023 | benzinga.comACHL Achilles Therapeutics plcDecember 20, 2023 | seekingalpha.comAchilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity PredictionDecember 18, 2023 | finance.yahoo.comSteelers lose Kwon Alexander for season with torn Achilles: reportsNovember 21, 2023 | foxnews.comAchilles Therapeutics GAAP EPS of -$0.42 misses by $0.02November 14, 2023 | msn.comAs Aaron Rodgers rehabs from torn Achilles, doctor offers insight into recoveryOctober 29, 2023 | foxnews.comAchilles Therapeutics PLC: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price RequirementSeptember 23, 2023 | finanznachrichten.deAre Medical Stocks Lagging Achilles Therapeutics (ACHL) This Year?September 22, 2023 | uk.style.yahoo.comAaron Rodgers says he's starting 'road to recovery' after Achilles surgery went 'great'September 21, 2023 | usatoday.com Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address ACHL Media Mentions By Week ACHL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACHL News Sentiment▼0.000.57▲Average Medical News Sentiment ACHL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACHL Articles This Week▼00▲ACHL Articles Average Week Get Achilles Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ACHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DBVT News SGMT News IMMP News ACB News NGNE News BTMD News SLRN News TVGN News CGC News PRQR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACHL) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACHL Stock Alerts